Discovery to IND capabilities:
We offer an extensive antibody discovery platform (CASH™) for novel therapeutics and an antibody humanization platform that utilizes best in class technology, we also have extensive supporting bioassays.Discovery & optimization
We can develop high quality, high titer manufacturing cell lines utilizing our own proprietary CHO-K1 derived cell line, CHOBC®. Utilizing our SPOT™ and SLIM™ technology we can reach titers upwards of 9 g/l.Cell line development
We can establish extensive physico-chemical and bioanalytical methods that are qualified in-house to fully characterize your biologic.Analytical development
We utilize our extensive knowledge in our process modulation toolbox to quickly establish processes that will yield the optimal outcome at the highest level of efficiency. We apply quality-by-design (QbD) principles to guarantee the quality, safety and efficacy of your products.Process development
State of the art microbial manufacturing facilities for fermentation recovery & purification development through to cGMP manufacturing for preclinical, clinical and commercial supply.
Drug product development and cGMP manufacturing of sterile biologicals in liquid and lyophilized forms at lab and large-scale.
Comprehensive biosimilar development capabilities from cell line development to commercial supply to help our partners provide patients access to the most advanced therapies available.